Immune-enhancing alkali-soluble glucans produced by wild-type and mutant Saccharomyces cerevisiae

Journal of Microbiology and Biotechnology

Volumn 16, Issue 4, 2006, Pages 576-583

  Ha, Chang Hoon ^a   Lim, Ki Hong ^a   Jang, Se Hwan ^a   Yun, Cheol Won ^a   Paik, Hyun Dong ^b   Kim, Seung Wook ^a   Kang, Chang Won ^b   Chang, Hyo Ihl ^a  

^a Korea University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Alkali soluble glucan; Mannoprotein; Random mutation; Yeast cell wall

Indexed keywords

ALKALI; BETA GLUCAN; ENDO 1,3 BETA GLUCANASE; GLUCAN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL WALL; CONTROLLED STUDY; DRY MASS; FUNGUS MUTANT; IMMUNITY; MACROPHAGE; MOUSE; MUTAGENESIS; NONHUMAN; PHAGOCYTOSIS; RADIATION EXPOSURE; SACCHAROMYCES CEREVISIAE; SOLUBILITY; STRUCTURE ANALYSIS; ULTRAVIOLET RADIATION; WILD TYPE; YEAST CELL;

ANIMALIA; FUNGI; SACCHAROMYCES CEREVISIAE;

EID: 33646572203     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Chorvatovicova J. Sandula and G. Kogan. 1999. Protective effect of the yeast glucomannan against cyclophosphamide-induced mutagenicity. Mutat. Res. 444: 117-122.
2. Czop, J. K. and J. Kay. 1991. Isolation and characterization of glucan receptors on human mononuclear phagocytes. J. Exp. Med. 173: 1511-1518.
3. Ding, A. H. and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141: 2407-2412.
4. Esteban, A. and J. Meseguer. 2004. Glucan receptor but not mannose receptor is involved in the phagocytosis of Saccharomyces cerevisiae by seabream (Sparus aurata L.) blood leucocytes. Fish Shellfish Immunol. 16: 447-451.
5. Fleet, G. H. and D. J. Manners. 1976. Isolation and composition of an alkali-soluble glucan from the cell walls of Saccharomyces. J. Gen. Microbiol. 94: 180-192.
6. Ha, C. H., Y. T. Kim, S. T. Lim, C. W. Kim, and H. I. Chang. 2002. Analysis of alkali-soluble glucan produced by Saccharomyces cerevisiae wild-type and mutants. Appl. Microbiol. Biotechnol. 58: 370-377.
7. Hong, F., J. Yan, D. J. Allendorf, J. T. Baran, G. R. Ostroff, and G. D. Ross. 2003. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res. 63: 9023-9031.
8. Hoffman, O. A. and A. H. Limper. 1993. Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. J. Immunol. 150: 3932-3940.
9. Ito, H., S. Kuroda, H. Sakamoto, J. Kajihara, T. Kiyota, H. Hayashi, M. Kato, and M. Seko. 1986. Molecular cloning and expression in Escherichia coli of the cDNA coding for rabbit tumor necrosis factor. DNA 5: 149-156.
10. Jamas, S., C. K. Rha, and A. J. Sinskey. 1986. Morphology of yeast cell wall as affected by genetic manipulation of (1-6) glycosidic linkage. Biotech. Bioeng. 28: 769-784.
11. Jamas, S., C. H. Osten, A. J. Sinskey, and C. K. Rha. 1990. Spectral analysis of glucan produced by wild-type and mutant Saccharomyces cerevisiae. Carbohydr. Polym. 13: 207-219.
12. Jung, K., Y. Ha, S. K. Ha, D. U. Han, D. W. Kim, W. K. Moon, and C. Chae. 2004. Antiviral effect of Saccharomyces cerevisiae beta-glucan to swine influenza virus by increased production of interferon-gamma and nitric oxide. J. Vet. Med. B. Infect. Dis. Vet. Public Health 51: 72-76.
13. Kollar, R., B. B. Reinhold, E. Petrakova, H. J. Yeh, G. Ashwell, J. Drgonova, J. C. Kapteyn, F. M. Klis, and E. Cabib. 1997. Architecture of the yeast cell wall. Beta(1→6)-glucan interconnects mannoprotein, beta(1→)3-glucan, and chitin. J. Biol. Chem. 272: 17762-17775.
14. Kramer, S. M. and M. E. Carver. 1986. Serum-free in vitro bioassay for the detection of tumor necrosis factor. J. Immunol. Methods 93: 201-208.
15. Kozel, T. R., A. Percival, and Q. Zhou. 2004. Biological activities of naturally occurring antibodies reactive with Candida albicans mannan. Infect. Immun. 72: 209-218.
16. Kurihara, K., N. N. Miura, S. Horie, Y. Usui, Y. Adachi, T. Yadomae, and N. Ohno. 2003. Effect of CAWS, a mannoprotein-beta-glucan complex of Candida albicans, on leukocyte, endothelial cell, and platelet functions in vitro. Biol. Pharm. Bull. 26: 233-240.
17. Lee, J. N., I. H. Ji, G. E. Kim, H. N. Kim, J. W. Sohn, S. D. Kim, and C. W. Kim. 2001. Purification of soluble beta glucan with immune enhancing activity from the cell wall of yeast. Biosci. Biotechnol. Biochem. 65: 837-841.
18. Luzio, S. 1961. Identification of a reticuloendothelial stimulating agent in zymosan. Am. J. Physiol. 200: 297-303.
19. Ohmura, Y., I. Motokawa, K. Sukarai, and T. Ando. 2001. Protective effects of a protein-bound polysaccharide, PSK, on Candida albicans infection in mice via tumor necrosis factor induction. Int. Immunopharmacol. 1: 1797-1811.
20. Ohno, N., T. Hashimoto, Y. Adachi, and T. Yadomae. 1996. Effect of glucans on the nitric oxide synthesis by peritoneal macrophage in mice. Biol. Pharm. Bull. 19: 608-612.
21. Price, C. W., G. B. Fuson, and H. J. Phaff. 1978. Genome comparison in yeast systematics: Delimitation of species within the genera Schwanniomyces, Saccharomyces, Debaryomyces, and Pichia. Microbiol. Rev. 42: 161-167.
22. Paulik, S., S. Svrcek, M. Huska, J. Mojzisova, A. Durove, and Z. Benisek. 1992. The effect of fungal and yeast glucan and levamisole on the level of the cellular immune response in vivo and leukocyte phagocytic activity in mice. Vet. Med. (Praha) 37: 675-681.
23. Ross, G. D., J. Yan, Y. Xia, and J. Vetvickova. 1999. Therapeutic intervention with complement and β-glucan in cancer. Immunopharmacology 42: 61-74.
24. Sakurai, T., N. Ohno, and T. Yadomae. 1999. Effects of fungal glucan and interferon on the secretory functions of murine alveolar macrophages. J. Leuk. Biol. 60: 118-124.
25. Soltys, J., P. Dubinsky, O. Tomasovicova, H. Auer, and H. Aspock. 1996. Effect of glucan immunomodulator on the immune response and larval burdens in mice with experimental toxocarosis. Appl. Parasitol. 37: 161-167.
26. Sakurai, T., N. Ohno, and T. Yadomae. 1994. Changes in immune mediators in mouse lung produced by administration of soluble (1→3)-beta-D-glucan. Biol. Pharm. Bull. 17: 617-624.
27. Stephen, X. R. A. Ruckmana, Joseph, F. Borzellecac, Chad, and B. Sanduskyd. 2004. Toxicological and metabolic investigations of the safety of N-a-Lauroyl-1-arginine ethyl ester monohydrochloride (LAE). Food Chem. Toxicol. 42: 245-259.
28. Schnyder, J. and M. Baggiolini. 1978. Role of phagocytosis in the activation of macrophages. J. Exp. Med. 148: 1449-1454.
29. Schnyder, J. and M. Baggiolini. 1978. Secretion of lysosomal hydrolases by stimulated and nonstimulated macrophages. J. Exp. Med. 148: 435-439.
30. Schnyder, J. and M. Baggiolini. 1980. Induction of plasminogen activator secretion in macrophages by electrochemical stimulation of the hexose monophosphate shunt with methylene blue. Proc. Natl. Acad. Sci. USA 77: 414-419.
31. Tsikitis, V. L., J. E. Albina, and J. S. Reichner. 2004. Beta-glucan affects leukocyte navigation in a complex chemotactic gradient. Surgery 136: 384-389.
32. Tsukada, C., H. Yokoyama, C. Miyaji, Y. Ishimoto, H. Kawamura, and T. Abo. 2003. Immunopotentiation of intraepithelial lymphocytes in the intestine by oral administrations of beta-glucan. Cell Immunol. 221: 1-5.
33. Vassallo, R. and A. H. Limper. 2000. Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J. Immunol. 164: 3755-3763.
34. Van Berkel, M. A., R. C. Montijn, and F. M. Klis. 1994. Glycosylation of chimeric proteins in the cell wall of Saccharomyces cerevisiae. FEBS Lett. 349: 135-138.
35. Williams, D. L., R. B. McNamee, E. L. Jones, H. E. Ensley, and I. W. Browder. 1992. Development of a water-soluble, sulfated (1→3)-beta-D-glucan biological response modifier derived from Saccharomyces cerevisiae. Carbohydr. Res. 235: 247-257.